338 Comparison of lymphodepleting chemotherapy regimens as preconditioning for T-cell therapies

• Stefan Zajic,
• Oleg Demin,
• Galina Kolesova,
• Natalia Ramos-Hernandez,
• Thomas Faitg,
• Lourdes Cucurull-Sanchez

Affiliations

Stefan Zajic

1GlaxoSmithKline, Collegeville, PA, USA

Oleg Demin

ISyBio, Moscow, Russian Federation

Galina Kolesova

2InSysBio, Moscow, Russian Federation

Natalia Ramos-Hernandez

3GlaxoSmithKline, Collegeville, PA, USA

Thomas Faitg

3GlaxoSmithKline, Collegeville, PA, USA

Lourdes Cucurull-Sanchez

4GlaxoSmithKline, Stevenage, UK